tiprankstipranks
Vor Biopharma (VOR)
NASDAQ:VOR
US Market
Holding VOR?
Track your performance easily

Vor Biopharma (VOR) Financial Statements

725 Followers

Vor Biopharma Financial Overview

Vor Biopharma's market cap is currently ―. The company's EPS TTM is $-1.649; its P/E ratio is ―; Vor Biopharma is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -27.56M$ -27.84M$ -28.12M$ -35.32M$ -32.17M
EBITDA$ -26.67M$ -27.27M$ -27.23M$ -35.32M$ -31.30M
Net Income Common Stockholders$ -27.56M$ -27.84M$ -26.26M$ -33.19M$ -29.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 62.81M$ 85.94M$ 137.18M$ 160.10M$ 186.90M
Total Assets$ 115.99M$ 141.59M$ 198.13M$ 223.02M$ 250.99M
Total Debt$ 32.85M$ 33.82M$ 35.66M$ 36.60M$ 37.51M
Net Debt$ -29.95M$ -52.12M$ -101.52M$ -123.50M$ -149.39M
Total Liabilities$ 43.04M$ 43.51M$ 47.40M$ 48.24M$ 46.54M
Stockholders Equity$ 72.95M$ 98.08M$ 150.72M$ 174.78M$ 204.45M
Cash Flow-
Free Cash Flow$ -23.32M$ -21.86M$ -24.14M$ -28.36M$ -24.50M
Operating Cash Flow$ -23.29M$ -21.85M$ -24.03M$ -27.90M$ -24.10M
Investing Cash Flow$ -34.00K$ 52.99M$ 10.34M$ 40.54M$ 13.64M
Financing Cash Flow$ 41.00K$ -31.00K$ 25.00K$ 176.00K$ 218.00K
Currency in USD

Vor Biopharma Earnings and Revenue History

Vor Biopharma Debt to Assets

Vor Biopharma Cash Flow

Vor Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis